Emblem Appoints New CFO to Take Company Through Next Phase of Growth
Toronto, Ontario, January 16, 2018 – Emblem Corp. (TSXV:EMC) (EMC.WT) (“Emblem” or the “Company”), is pleased to announce the appointment of Alex Stojanovic as Chief Financial Officer of the Company effective immediately. Mr. Stojanovic will replace Mr. John Laurie who will be stepping down going forward.
As CFO at Emblem, Mr. Stojanovic will be responsible for ensuring the finance department can enable the Company to continue to drive growth, capitalizing on the growing demand for premium cannabis products across Emblem’s Medical, Pharmaceutical and Recreational product verticals.
“First, on behalf of our entire team and the board of directors, I would like to thank John for his dedication and contributions in Emblem’s accomplishments thus far and wish him the best in the future. Alex brings a strong background to our finance team from his experience at other companies where he was instrumental in providing the financial strategy and leadership to help the organizations get to the next level of growth,” said Nick Dean, President and CEO of Emblem Corp. “With Alex, I’m confident we’ll be well positioned to meet our objectives concerning our capital planning as we accelerate growth and build a leadership position for our brand and products moving forward. We’re excited to have him on the Emblem team.”
Mr. Stojanovic joined Emblem as Director of Finance in August, 2017. Previously, he held several senior finance positions in Barrick Gold Corporation and Teranga Gold Corporation, including an assignment in Chile overseeing the finance team on a multibillion dollar construction project. Mr. Stojanovic has extensive experience in external reporting and compliance, business planning, capital markets activities, internal controls, corporate governance and team development. He began his career in public accounting, gaining valuable experience as an auditor and tax specialist. He holds a Bachelor of Commerce degree from the University of Western Ontario and is a Chartered Professional Accountant as well as a Chartered Financial Analyst charter holder.
Emblem Corp. is a fully integrated licensed producer and distributor of medical cannabis and cannabis derivatives in Canada under the ACMPR (Access to Cannabis for Medical Purposes Regulations). Led by a team of cannabis experts and former health care and pharma executives, it has three distinct verticals – cannabis production, patient education centers, and pharmaceutical dosage form development. Emblem trades under the ticker symbol EMC on the Toronto Venture Exchange (TSXV).
For further information contact:
Vice President, Capital Markets and Investor Relations
This news release may contain “forward-looking information” and “forward-looking statements” within the meaning of applicable Canadian securities legislation (together, “forward-looking statements”). All statements and information contained herein that is not clearly historical in nature may constitute forward-looking statement. Forward-looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable by management, are inherently subject to significant business, economic and competitive risks, uncertainties and contingencies that may cause actual financial results, performance or achievements to be materially different from the estimated future results, performance or achievements expressed or implied by those forward-looking statements.
Forward-looking statements are not a guarantee of future performance and are subject to and involve a number of known and unknown risks and uncertainties, many of which are beyond the control of the Company, which may cause the Company’s actual performance and results to differ materially from any projections of future performance or results expressed or implied by such forward-looking statements. These risks and uncertainties include, but are not limited to, the risks identified in the Company’s annual information form dated October 18, 2017 which has been filed with the Canadian Securities Administrators and is available on www.sedar.com. Any forward-looking statements are made as of the date hereof and, except as required by law, the Company assumes no obligation to publicly update or revise such statements to reflect new information, subsequent or otherwise.
Readers are cautioned not to put undue reliance on these forward-looking statements. This news release contains information obtained by the Company from third parties and believes such information to be accurate but has not independently verified such information.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.